Literature DB >> 25274557

From hypomagnesaemia to Zollinger-Ellison syndrome: an adverse effect of a proton pump inhibitor.

Allon Eyal1, Alain Sueissa2, Eyal Braun3, Mohammad Ebrahim Naffaa4.   

Abstract

We describe the case of a 53-year-old man who presented with abdominal pain, diarrhoea and hypomagnesaemia. The hypomagnesaemia proved to be due to gastrointestinal loss as urinary fractional excretion was very low, suggesting non-renal loss. Common causes were discarded and the hypomagnesaemia was attributed to chronic use of the proton pump inhibitor, omeprazole. As such, omeprazole was discontinued and an H2 blocker was given. Several days later the patient presented with upper gastrointestinal bleeding. CT scan demonstrated marked enlargement of the duodenum and proximal jejunum, and abnormal thickening and enhancement of the bowel wall. Urgent oesophagogastroduodenoscopy revealed coffee-ground and bloody contents in the distal oesophagus and stomach, and numerous ulcers along the duodenum and jejunum. A positron emission tomography-CT scan using GA 68-DOTANOC demonstrated increased uptake in the gastroduodenum junction, suggesting a neuroendocrine tumour. Pancreaticoduodenectomy was performed and tumour cells stained positive for gastrin, confirming the tentative diagnosis of Zollinger-Ellison syndrome. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25274557      PMCID: PMC4187419          DOI: 10.1136/bcr-2014-205165

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Proton-pump inhibitors and hypomagnesemic hypoparathyroidism.

Authors:  Martin Epstein; Shaun McGrath; Florence Law
Journal:  N Engl J Med       Date:  2006-10-26       Impact factor: 91.245

Review 2.  The Zollinger-Ellison syndrome: a comprehensive review of historical, scientific, and clinical considerations.

Authors:  E Christopher Ellison; Jerome A Johnson
Journal:  Curr Probl Surg       Date:  2009-01       Impact factor: 1.909

Review 3.  Diagnosis of Zollinger-Ellison syndrome: increasingly difficult.

Authors:  Tetsuhide Ito; Guillaume Cadiot; Robert T Jensen
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

4.  Modeling and simulation of the effect of proton pump inhibitors on magnesium homeostasis. 1. Oral absorption of magnesium.

Authors:  Jane P F Bai; Ethan Hausman; Robert Lionberger; Xinyuan Zhang
Journal:  Mol Pharm       Date:  2012-11-02       Impact factor: 4.939

5.  Lymph nodes metastasis and recurrences justify an aggressive treatment of gastrinoma.

Authors:  Francesco Giovinazzo; Giovanni Butturini; Daniela Monsellato; Giuseppe Malleo; Giovanni Marchegiani; Claudio Bassi
Journal:  Updates Surg       Date:  2013-02-16

6.  A case series of proton pump inhibitor-induced hypomagnesemia.

Authors:  Ewout J Hoorn; Joost van der Hoek; Rob A de Man; Ernst J Kuipers; Clemens Bolwerk; Robert Zietse
Journal:  Am J Kidney Dis       Date:  2010-02-26       Impact factor: 8.860

Review 7.  Proton pump inhibitors: potential adverse effects.

Authors:  Neena S Abraham
Journal:  Curr Opin Gastroenterol       Date:  2012-11       Impact factor: 3.287

8.  Zollinger-Ellison syndrome. Clinical presentation in 261 patients.

Authors:  P K Roy; D J Venzon; H Shojamanesh; A Abou-Saif; P Peghini; J L Doppman; F Gibril; R T Jensen
Journal:  Medicine (Baltimore)       Date:  2000-11       Impact factor: 1.889

9.  Uses of proton pump inhibitors and hypomagnesemia.

Authors:  Jen-Tzer Gau; Yu-Xiao Yang; Roger Chen; Tzu-Cheg Kao
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-02-15       Impact factor: 2.890

10.  Proton-pump inhibitor use is associated with low serum magnesium concentrations.

Authors:  John Danziger; Jeffrey H William; Daniel J Scott; Joon Lee; Li-wei Lehman; Roger G Mark; Michael D Howell; Leo A Celi; Kenneth J Mukamal
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

View more
  2 in total

Review 1.  A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors.

Authors:  Li-Yuan Yu; Lu-Ning Sun; Xue-Hui Zhang; Yue-Qi Li; Lei Yu; Zi-Qing-Yun Yuan; Ling Meng; Hong-Wen Zhang; Yong-Qing Wang
Journal:  Adv Ther       Date:  2017-04-20       Impact factor: 3.845

2.  Gastrin Induces Nuclear Export and Proteasome Degradation of Menin in Enteric Glial Cells.

Authors:  Sinju Sundaresan; Cameron A Meininger; Anthony J Kang; Amanda L Photenhauer; Michael M Hayes; Nirakar Sahoo; Jolanta Grembecka; Tomasz Cierpicki; Lin Ding; Thomas J Giordano; Tobias Else; David J Madrigal; Malcolm J Low; Fiona Campbell; Ann-Marie Baker; Haoxing Xu; Nicholas A Wright; Juanita L Merchant
Journal:  Gastroenterology       Date:  2017-08-30       Impact factor: 33.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.